• picture

What is NEO-CIRC?

Neo-Circ Consortium


- will focus on the use of the drug dobutamine for the treatment of circulatory failure in the first two days after birth

- sustained low blood pressure and impaired blood flow to organs, during this period, can cause brain injury resulting in poor neurodevelopmental outcomes

- neurodevelopmental disorders are associated with mental, emotional and physical disorders of varying severity

- there is strong evidence that the use of dobutamine will reduce the incidence of these disabilities


Latest news

NeoCirc-001A completed!
The 1st phase of NEOCIRC001 trial is complete after recruiting the required number of babies.

NEOCIRC participates at the First Annual Neonatal Scientific Workshop in USA
M Turner and H Rabe were an invited Panel members and Speakers at the First Annual Neonatal Scientific Workshop.

2nd Period summary
The summary of the 2nd Period of NEOCIRC project work is now available!

View all news >>


4th NEO-CIRC Consortium Meeting

The 4th NEO-CIRC Consortium Meeting to take place in the city of Cluj-Napoca in Romania.

NEO-CIRC Consortium Meeting Scheduled

The next NEO-CIRC Consortium Meeting will be held in Lübeck, Germany on the 19th – 20th March 2013.

NEO-CIRC Consortium Meeting held in Madrid.

The first consortium meeting was held in Madrid on the 12-13th June 2012. The meeting was hosted by NEO-CIRC partner- Servicio Madrileño De Salud (Sermas).

View all events >>